Holen Sie sich die Stockscreener-App
3.12
3.11%
-0.10
Schlusskurs vom Vortag:
$3.22
Offen:
$3.24
24-Stunden-Volumen:
47,370
Relative Volume:
0.09
Marktkapitalisierung:
$3.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.42M
KGV:
-1.6957
EPS:
-1.84
Netto-Cashflow:
$-13.41M
1W Leistung:
-12.11%
1M Leistung:
-4.59%
6M Leistung:
+578.26%
1J Leistung:
+167.81%
1-Tages-Spanne:
$2.945
$3.33
1-Wochen-Bereich:
$2.945
$3.64
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Vergleichen Sie INDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
3.12 | 3.56M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Visual trend scoring systems applied to Indaptus Therapeutics Inc.July 2025 Patterns & Weekly Top Stock Performers List - newser.com
Can Indaptus Therapeutics Inc. stock double in next 5 yearsJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
Does Indaptus Therapeutics Inc. fit your quant trading model2025 Dividend Review & Verified Entry Point Signals - newser.com
Why Indaptus Therapeutics Inc. stock could see breakout soonJuly 2025 Levels & Daily Oversold Bounce Ideas - newser.com
Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsWatch List & Accurate Technical Buy Alerts - newser.com
How high can Indaptus Therapeutics Inc. stock goWatch List & Growth Focused Entry Point Reports - newser.com
Is Indaptus Therapeutics Inc. stock ready for a breakoutAnalyst Upgrade & Community Verified Watchlist Alerts - newser.com
Why analysts upgrade Indaptus Therapeutics Inc. stockJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Will earnings trigger a reversal in Indaptus Therapeutics Inc.Weekly Risk Summary & Entry Point Confirmation Signals - newser.com
Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Take Profit & Expert Curated Trade Setup Alerts - newser.com
Key resistance and support levels for Indaptus Therapeutics Inc.Trade Volume Report & Daily Entry Point Alerts - newser.com
What momentum indicators show for Indaptus Therapeutics Inc. stockWeekly Volume Report & Daily Price Action Insights - newser.com
Volume spikes in Indaptus Therapeutics Inc. stock – what they meanQuarterly Market Review & Comprehensive Market Scan Reports - newser.com
Volatility clustering patterns for Indaptus Therapeutics Inc.2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
How Indaptus Therapeutics Inc. stock performs in interest rate cycles2025 Dividend Review & Smart Allocation Stock Tips - newser.com
Why retail investors pile into Indaptus Therapeutics Inc. stockJuly 2025 Drop Watch & Consistent Growth Stock Picks - newser.com
How Indaptus Therapeutics Inc. stock performs in rising dollar environmentAnalyst Upgrade & AI Based Buy and Sell Signals - newser.com
Building trade automation scripts for Indaptus Therapeutics Inc.Take Profit & Long-Term Capital Growth Strategies - newser.com
Backtesting results for Indaptus Therapeutics Inc. trading strategies2025 Fundamental Recap & High Accuracy Investment Signals - newser.com
What Wall Street predicts for Indaptus Therapeutics Inc. stock priceJuly 2025 Outlook & AI Based Buy/Sell Signal Reports - newser.com
Indaptus Therapeutics (INDP) Price Target Decreased by 86.15% to 25.50 - MSN
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):